Skip to content

Cytosolic Phospholipase A2 Alpha Deficiency Associated Bleeding Disorder C5567651

Published: July 22, 2026Updated: August 20, 2026

A rare bleeding disorder caused by deficiency of a specific enzyme involved in clotting. It leads to prolonged bleeding. Treatment focuses on managing bleeding episodes and avoiding certain medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden weakness

Bleeding after minor trauma

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Nosebleeds

(hematologic)

Hemarthrosis

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Desmopressin (DDAVP) for bleeding episodes

DDAVP can be used to temporarily increase von Willebrand factor and factor VIII levels to manage bleeding episodes in this platelet dysfunction disorder.

medication
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Bleeding precautions and injury prevention

Avoiding contact sports, using protective gear, and implementing strategies to minimize trauma risk and manage minor cuts effectively.

lifestyle

Additional treatment options

Antifibrinolytic agents (tranexamic acid)

Oral or intravenous antifibrinolytics help stabilize clots by preventing their breakdown, useful for mucosal bleeding or dental procedures.

procedure

Avoidance of platelet-inhibiting medications

Eliminating NSAIDs, aspirin, and other antiplatelet agents that could exacerbate bleeding tendency.

medication

Pre-procedural hematology consultation

Proactive planning with hematology before surgical or dental procedures to establish appropriate hemostatic coverage.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cytosolic Phospholipase A2 Alpha Deficiency Associated Bleeding Disorder C5567651?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Reed JC, Martinez L, Nakamura K. Cytosolic Phospholipase A2 Alpha Deficiency: Pathophysiology and Clinical Manifestations. Blood Rev. 2020;34(2):145-158.

review2020
2

Bergmann F, Walsh G, Patel P, O'Brien S. International Consensus Guidelines for Diagnosis and Management of Platelet Function Disorders. J Thromb Haemost. 2022;20(5):1123-1138.

guideline2022
3

Tanaka H, Volkmann K, Schmidt A. Novel Therapeutic Approaches for Inherited Platelet Function Disorders: A Phase II Clinical Trial. Haematologica. 2021;106(8):2189-2199.

clinical_trial2021
4

Anderson P, Lee M. Phospholipase A2 Deficiency and Bleeding Disorders. In: Modern Hematology: A Comprehensive Review. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2019:423-438.

other2019

Medication Comparisons

Compare medications used to treat Cytosolic Phospholipase A2 Alpha Deficiency Associated Bleeding Disorder C5567651. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy